Klinische Studie
Smart water bottles and coaching increased hydration but did not cut kidney stone recurrences, trial finds
Von KI berichtet Bild generiert von KI Fakten geprüft
In a two-year U.S. trial of 1,658 adolescents and adults with prior kidney stones, a technology-assisted hydration program modestly increased urine output but did not significantly reduce symptomatic stone recurrences compared with standard care.
A one-year course of the drug abatacept can delay the onset of rheumatoid arthritis by up to four years in high-risk individuals. The benefits persisted long after treatment stopped, according to new research from King's College London.
Von KI berichtet
A minimally invasive procedure called duodenal mucosal resurfacing may help patients maintain weight loss after discontinuing drugs like Ozempic and tirzepatide. Early results from the REMAIN-1 clinical trial show treated participants regained far less weight than those in a control group after six months off medication. The findings are set for presentation at Digestive Disease Week 2026.
Das Comandante Faustino Pérez Provinzialklinische Chirurgische Krankenhaus hat eine klinische Studie mit dem kubanischen Medikament Jusvinza zur Behandlung der residualen Polyarthritis bei Chikungunya-Überlebenden gestartet. Die Studie bewertet die Fähigkeit des Medikaments, anhaltende Schmerzen und Gelenkentzündungen zu reduzieren. Sie umfasst 120 Patienten und zielt auf eine erschwingliche Behandlungsoption ab.
Von KI berichtet
In der kubanischen Provinz Matanzas hat eine klinische Studie für das Medikament Jusvinza begonnen, das vom Zentrum für Gentechnik und Biotechnologie (CIGB) entwickelt wurde. Das Medikament zielt auf residuelle Polyarthritis bei Patienten ab, die sich von Chikungunya erholen. Dieser Schritt stellt einen Fortschritt in den lokalen Gesundheitsbemühungen dar.
A Korean clinical trial has demonstrated that low-dose radiation therapy significantly reduces pain and improves mobility in patients with mild to moderate knee osteoarthritis, outperforming placebo effects. The treatment, which uses doses far below those for cancer, showed no side effects and could serve as an alternative to medications or surgery. Results were presented at the American Society for Radiation Oncology Annual Meeting.
Von KI berichtet
A new topical serum containing plant extracts and growth proteins has shown promising results in increasing hair density and thickness within 56 days. Developed by researchers in Taiwan, the treatment outperformed a placebo in a small clinical trial involving 60 adults. While encouraging, experts call for larger studies to confirm its efficacy.